Premium
P4‐251: Cessation versus continuation of 12 months galantamine therapy in patients with Alzheimer's disease: A randomised, double blind, placebo controlled withdrawal trial
Author(s) -
Adami Marina,
Scarpini Elio,
Bruno Guiseppe,
Zappala Guiseppe,
Richarz Ute,
Gaudig Maren,
Jacobs Adam,
Schaeuble Barbara
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.2276
Subject(s) - galantamine , placebo , hazard ratio , medicine , confidence interval , clinical endpoint , randomized controlled trial , post hoc analysis , dementia , psychiatry , psychology , donepezil , disease , alternative medicine , pathology
Results of remote reminiscence talking: The psychological stability was compared on the GBS check sheets. The average score was 0.92 for the A period, and 0.42 for the B period Results of the scheduling system: The average percentage of accomplished scheduled tasks was 55.1% for the A period, and 79.7% for the B period. Conclusions: Operating and maintaining this system during the field experiment was very challenging. However, we are greatly encouraged that two subjects and family caregivers have continued to use our system. We believe that our remote assistance system has great potential.